Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Pre-emptive Anakinra for the Prevention of Severe Cytokine Release Syndrome in Children and Young Adults With B-Acute Lymphoblastic Leukemia Receiving Chimeric Antigen Receptor (CAR) T Cells

NCT06703216 is registered in ClinicalTrials.gov with Kevin McNerney as lead sponsor.

NCT NCT06703216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06703216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Pre-emptive Anakinra for the Prevention of Severe Cytokine Release Syndrome in Children and Young Adults With B-Acute Lymphoblastic Leukemia Receiving Chimeric Antigen Receptor (CAR) T Cells
Lead sponsor
Kevin McNerney
Phase
Phase 1/2
Overall status
Withdrawn
Start date
October 31, 2026
Completion date
February 28, 2030
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-acute lymphoblastic leukemia, car-t cell therapy, cytokine release syndrome, immune effector cell associated hemophagocytic lymphohistiocytosis-like syndrome, immune effector cell associated neurotoxicity syndrome